Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects

There is an urgent need for a universally effective HIV-1 vaccine, but whether a vaccine will be able to protect against HIV-1 of different clades is a significant concern. IgA from HIV-1-exposed, persistently seronegative (HEPS) subjects has been shown to neutralize HIV-1 and to block epithelial HI...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of acquired immune deficiency syndromes (1999) 2002-08, Vol.30 (4), p.413-420
Hauptverfasser:	DEVITO, Claudia, HINKULA, Jorma, PLUMMER, Francis, CLERICI, Mario, BROLIDEN, Kristina, KAUL, Rupert, KIMANI, Joshua, KIAMA, Peter, LOPALCO, Lucia, BARASS, Claudia, PICONI, Stefania, TRABATTONI, Daria, BWAYO, Job J
Format:	Artikel
Sprache:	eng
Schlagworte:	AIDS Vaccines - immunology AIDS/HIV Biological and medical sciences Case-Control Studies Cross Reactions Drug therapy Female Heterosexuality HIV HIV Antibodies - metabolism HIV Envelope Protein gp160 - immunology HIV Infections - immunology HIV Infections - prevention & control HIV Infections - transmission HIV Seronegativity - immunology HIV-1 - classification HIV-1 - immunology Human immunodeficiency virus Human viral diseases Humans Immunity, Mucosal Immunoglobulin A - metabolism Immunoglobulin A, Secretory - metabolism Infectious diseases Kenya Male Medical research Medical sciences Neutralization Tests Recombinant Proteins - immunology Saliva - immunology Sex Work Sexual Partners Vaccines Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!